CERUS CORP Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five
CERUS CORP (CERS) had Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five of $15.11 million as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Notes › Debt and Equity Securities › Available-for-Sale Securities, Debt Maturities › Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value
us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue · last filed 2026-07-30
- 2026-06-30: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five $15.11M.
- 2026-03-31: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five $16.39M.
- 2025-12-31: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five $18.52M.
- 2025-09-30: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five $11.23M.
| Period end | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five |
|---|---|
| 2026-06-30 | $15.11M 10-Q · filed 2026-07-30 |
| 2026-03-31 | $16.39M 10-Q · filed 2026-04-30 |
| 2025-12-31 | $18.52M 10-Q · filed 2026-07-30 |
| 2025-09-30 | $11.23M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $17.57M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $19.83M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $23.79M 10-K · filed 2026-03-02 |
| 2024-09-30 | $22.91M 10-Q · filed 2024-10-31 |
| 2024-06-30 | $20.48M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $15.84M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $17.48M 10-K · filed 2025-02-26 |
| 2023-09-30 | $35.99M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $45.19M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $51.35M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $53.13M 10-K · filed 2024-03-05 |
| 2022-09-30 | $54.01M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $49.05M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $41.26M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $42.82M 10-K · filed 2023-03-01 |
| 2021-09-30 | $10.20M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $17.43M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $25.73M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $38.09M 10-K · filed 2022-02-22 |
| 2020-09-30 | $43.33M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $50.59M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $55.59M 10-Q · filed 2020-05-05 |
| 2019-12-31 | $15.69M 10-K · filed 2021-02-25 |
| 2019-09-30 | $12.62M 10-Q · filed 2019-10-30 |
| 2019-06-30 | $22.63M 10-Q · filed 2019-08-01 |
| 2018-12-31 | $9.93M 10-K · filed 2020-02-21 |
| 2018-09-30 | $27.90M 10-Q · filed 2018-11-01 |
| 2018-06-30 | $46.76M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $62.30M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $11.99M 10-K · filed 2019-02-27 |
| 2017-09-30 | $6.00M 10-Q · filed 2017-11-03 |
| 2016-09-30 | $4.00M 10-Q · filed 2016-11-04 |
| 2016-06-30 | $10.14M 10-Q · filed 2016-08-05 |
| 2016-03-31 | $20.23M 10-Q · filed 2016-05-06 |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-08 |
| 2014-12-31 | $5.70M 10-K · filed 2016-03-09 |
| 2013-12-31 | $6.14M 10-K · filed 2015-03-16 |
| 2013-09-30 | $12.34M 10-Q · filed 2013-11-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Orthofix Medical Inc. (OFIX) | $0.373B |